日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Bronchoalveolar fluid and plasma inflammatory biomarkers in contemporary ARDS patients.

当代 ARDS 患者的支气管肺泡液和血浆炎症生物标志物

Stapleton Renee D, Suratt Benjamin T, Neff Margaret J, Wurfel Mark M, Ware Lorraine B, Ruzinski John T, Caldwell Ellen, Hallstrand Teal S, Parsons Polly E

Genetic variation in the FAS gene and associations with acute lung injury

FAS基因的遗传变异及其与急性肺损伤的关联

Glavan, Bradford J; Holden, Tarah D; Goss, Christopher H; Black, R Anthony; Neff, Margaret J; Nathens, Avery B; Martin, Thomas R; Wurfel, Mark M

A phase II randomized placebo-controlled trial of omega-3 fatty acids for the treatment of acute lung injury.

一项针对急性肺损伤的ω-3脂肪酸治疗的II期随机安慰剂对照试验

Stapleton Renee D, Martin Thomas R, Weiss Noel S, Crowley Joseph J, Gundel Stephanie J, Nathens Avery B, Akhtar Saadia R, Ruzinski John T, Caldwell Ellen, Curtis J Randall, Heyland Daren K, Watkins Timothy R, Parsons Polly E, Martin Julie M, Wurfel Mark M, Hallstrand Teal S, Sims Kathryn A, Neff Margaret J

Mitogen-activated protein kinases in the intensive care unit: prognostic potential

重症监护病房中的丝裂原活化蛋白激酶:预后潜力

Rosengart, Matthew R; Nathens, Avery B; Arbabi, Saman; Neff, Margaret J; Garcia, Iris; Martin, Thomas R; Maier, Ronald V

Randomized, prospective trial of antioxidant supplementation in critically ill surgical patients

一项针对危重外科患者补充抗氧化剂的随机前瞻性试验

Nathens, Avery B; Neff, Margaret J; Jurkovich, Gregory J; Klotz, Patricia; Farver, Katherine; Ruzinski, John T; Radella, Frank; Garcia, Iris; Maier, Ronald V